Healthcare · Industry

Biotechnology - List & Prices (656 stocks)

By market cap Page 7 of 14 Prices: Sep 4, 2026 close

Biotechnology - List & Prices
#	Company	Ticker	Price	Mkt cap	P/E	Div yield
301	Vanda Pharmaceuticals Inc.	VNDA	$5.43	$328.31M	unprofitable	—
302	InflaRx N.V. Common Stock	IFRX	$2.22	$327.16M	unprofitable	—
303	Vicore Pharma Holding AB (publ)	VCRE	$11.59	$326.29M	unprofitable	—
304	Cellectis S.A.	CLLS	$3.24	$326.27M	unprofitable	—
305	Pyxis Oncology, Inc.	PYXS	$3.89	$324.46M	unprofitable	—
306	Sionna Therapeutics, Inc.	SION	$7.18	$324.18M	unprofitable	—
307	Immuneering Corporation	IMRX	$4.82	$311.84M	unprofitable	—
308	Orchestra BioMed Holdings, Inc.	OBIO	$5.08	$305.33M	unprofitable	—
309	Bicycle Therapeutics plc	BCYC	$4.30	$300.97M	unprofitable	—
310	Turn Therapeutics Inc.	TTRX	$9.80	$297.60M	unprofitable	—
311	Fate Therapeutics, Inc.	FATE	$2.48	$297.15M	unprofitable	—
312	Fulcrum Therapeutics, Inc.	FULC	$3.85	$293.74M	unprofitable	—
313	Foghorn Therapeutics Inc.	FHTX	$4.92	$292.18M	unprofitable	—
314	ProQR Therapeutics N.V.	PRQR	$2.07	$292.12M	unprofitable	—
315	AC Immune SA	ACIU	$2.86	$284.36M	unprofitable	—
316	Cartesian Therapeutics, Inc.	RNAC	$9.27	$280.47M	unprofitable	—
317	MacroGenics, Inc.	MGNX	$4.40	$280.28M	unprofitable	—
318	ALX Oncology Holdings Inc.	ALXO	$2.01	$277.94M	unprofitable	—
319	Entrada Therapeutics, Inc.	TRDA	$7.13	$277.62M	unprofitable	—
320	CAMP4 THERAPEUTICS CORPORATION	CAMP	$4.41	$276.74M	unprofitable	—
321	Alector, Inc.	ALEC	$2.46	$274.68M	unprofitable	—
322	Lineage Cell Therapeutics, Inc.	LCTX	$1.08	$273.14M	unprofitable	—
323	Surrozen, Inc.	SRZN	$22.76	$267.51M	unprofitable	—
324	Anavex Life Sciences Corp.	AVXL	$2.86	$265.11M	unprofitable	—
325	Satellos Bioscience Inc.	MSCL.TO	CA$12.45	CA$264.14M	unprofitable	—
326	Whitehawk Therapeutics, Inc.	WHWK	$4.60	$262.24M	unprofitable	—
327	YD Bio Ltd	YDES	$3.54	$250.74M	—	—
328	NervGen Pharma Corp.	NGEN	$2.33	$250.53M	unprofitable	—
329	Veraxa Biotech AG	VRXA	$1.76	$248.88M	unprofitable	—
330	Neumora Therapeutics, Inc.	NMRA	$1.31	$246.14M	unprofitable	—
331	Eledon Pharmaceuticals, Inc.	ELDN	$3.02	$245.41M	unprofitable	—
332	Compugen Ltd.	CGEN	$2.59	$245.34M	6.8	—
333	Invivyd, Inc.	IVVD	$0.83	$243.47M	unprofitable	—
334	Atrium Therapeutics, Inc.	RNA	$14.19	$242.73M	unprofitable	—
335	Adagene Inc.	ADAG	$3.58	$240.37M	unprofitable	—
336	Greenwich LifeSciences, Inc.	GLSI	$15.95	$234.12M	unprofitable	—
337	Protara Therapeutics, Inc.	TARA	$3.94	$232.84M	unprofitable	—
338	Innate Pharma S.A.	IPHA	$2.08	$232.34M	unprofitable	—
339	Acumen Pharmaceuticals, Inc.	ABOS	$3.18	$229.97M	unprofitable	—
340	Sol-Gel Technologies Ltd.	SLGL	$69.52	$227.61M	unprofitable	—
341	Tonix Pharmaceuticals Holding Corp.	TNXP	$13.14	$225.36M	unprofitable	—
342	Keros Therapeutics, Inc.	KROS	$11.32	$224.44M	unprofitable	—
343	AN2 Therapeutics, Inc.	ANTX	$5.89	$222.27M	unprofitable	—
344	Coherus Oncology, Inc.	CHRS	$1.42	$219.39M	unprofitable	—
345	Armata Pharmaceuticals, Inc.	ARMP	$5.84	$217.14M	unprofitable	—
346	Voyager Therapeutics, Inc.	VYGR	$3.51	$216.28M	unprofitable	—
347	Protalix BioTherapeutics, Inc.	PLX	$2.67	$215.13M	11.6	—
348	PepGen Inc.	PEPG	$3.11	$215.12M	unprofitable	—
349	Corbus Pharmaceuticals Holdings, Inc.	CRBP	$11.08	$214.30M	unprofitable	—
350	Minerva Neurosciences, Inc.	NERV	$4.43	$211.52M	unprofitable	—

VNDA

Vanda Pharmaceuticals Inc.

$5.43

Healthcare / Biotechnology

Market Cap: $328.31M
P/E: unprofitable

IFRX

InflaRx N.V. Common Stock

$2.22

Healthcare / Biotechnology

Market Cap: $327.16M
P/E: unprofitable

VCRE

Vicore Pharma Holding AB (publ)

$11.59

Healthcare / Biotechnology

Market Cap: $326.29M
P/E: unprofitable

CLLS

Cellectis S.A.

$3.24

Healthcare / Biotechnology

Market Cap: $326.27M
P/E: unprofitable

PYXS

Pyxis Oncology, Inc.

$3.89

Healthcare / Biotechnology

Market Cap: $324.46M
P/E: unprofitable

SION

Sionna Therapeutics, Inc.

$7.18

Healthcare / Biotechnology

Market Cap: $324.18M
P/E: unprofitable

IMRX

Immuneering Corporation

$4.82

Healthcare / Biotechnology

Market Cap: $311.84M
P/E: unprofitable

OBIO

Orchestra BioMed Holdings, Inc.

$5.08

Healthcare / Biotechnology

Market Cap: $305.33M
P/E: unprofitable

BCYC

Bicycle Therapeutics plc

$4.30

Healthcare / Biotechnology

Market Cap: $300.97M
P/E: unprofitable

TTRX

Turn Therapeutics Inc.

$9.80

Healthcare / Biotechnology

Market Cap: $297.60M
P/E: unprofitable

FATE

Fate Therapeutics, Inc.

$2.48

Healthcare / Biotechnology

Market Cap: $297.15M
P/E: unprofitable

FULC

Fulcrum Therapeutics, Inc.

$3.85

Healthcare / Biotechnology

Market Cap: $293.74M
P/E: unprofitable

FHTX

Foghorn Therapeutics Inc.

$4.92

Healthcare / Biotechnology

Market Cap: $292.18M
P/E: unprofitable

PRQR

ProQR Therapeutics N.V.

$2.07

Healthcare / Biotechnology

Market Cap: $292.12M
P/E: unprofitable

ACIU

AC Immune SA

$2.86

Healthcare / Biotechnology

Market Cap: $284.36M
P/E: unprofitable

RNAC

Cartesian Therapeutics, Inc.

$9.27

Healthcare / Biotechnology

Market Cap: $280.47M
P/E: unprofitable

MGNX

MacroGenics, Inc.

$4.40

Healthcare / Biotechnology

Market Cap: $280.28M
P/E: unprofitable

ALXO

ALX Oncology Holdings Inc.

$2.01

Healthcare / Biotechnology

Market Cap: $277.94M
P/E: unprofitable

TRDA

Entrada Therapeutics, Inc.

$7.13

Healthcare / Biotechnology

Market Cap: $277.62M
P/E: unprofitable

CAMP

CAMP4 THERAPEUTICS CORPORATION

$4.41

Healthcare / Biotechnology

Market Cap: $276.74M
P/E: unprofitable

ALEC

Alector, Inc.

$2.46

Healthcare / Biotechnology

Market Cap: $274.68M
P/E: unprofitable

LCTX

Lineage Cell Therapeutics, Inc.

$1.08

Healthcare / Biotechnology

Market Cap: $273.14M
P/E: unprofitable

SRZN

Surrozen, Inc.

$22.76

Healthcare / Biotechnology

Market Cap: $267.51M
P/E: unprofitable

AVXL

Anavex Life Sciences Corp.

$2.86

Healthcare / Biotechnology

Market Cap: $265.11M
P/E: unprofitable

MSCL.TO

Satellos Bioscience Inc.

CA$12.45

Healthcare / Biotechnology

Market Cap: CA$264.14M
P/E: unprofitable

WHWK

Whitehawk Therapeutics, Inc.

$4.60

Healthcare / Biotechnology

Market Cap: $262.24M
P/E: unprofitable

YDES

YD Bio Ltd

$3.54

Healthcare / Biotechnology

Market Cap: $250.74M

NGEN

NervGen Pharma Corp.

$2.33

Healthcare / Biotechnology

Market Cap: $250.53M
P/E: unprofitable

VRXA

Veraxa Biotech AG

$1.76

Healthcare / Biotechnology

Market Cap: $248.88M
P/E: unprofitable

NMRA

Neumora Therapeutics, Inc.

$1.31

Healthcare / Biotechnology

Market Cap: $246.14M
P/E: unprofitable

ELDN

Eledon Pharmaceuticals, Inc.

$3.02

Healthcare / Biotechnology

Market Cap: $245.41M
P/E: unprofitable

CGEN

Compugen Ltd.

$2.59

Healthcare / Biotechnology

Market Cap: $245.34M
P/E: 6.8

IVVD

Invivyd, Inc.

$0.83

Healthcare / Biotechnology

Market Cap: $243.47M
P/E: unprofitable

RNA

Atrium Therapeutics, Inc.

$14.19

Healthcare / Biotechnology

Market Cap: $242.73M
P/E: unprofitable

ADAG

Adagene Inc.

$3.58

Healthcare / Biotechnology

Market Cap: $240.37M
P/E: unprofitable

GLSI

Greenwich LifeSciences, Inc.

$15.95

Healthcare / Biotechnology

Market Cap: $234.12M
P/E: unprofitable

TARA

Protara Therapeutics, Inc.

$3.94

Healthcare / Biotechnology

Market Cap: $232.84M
P/E: unprofitable

IPHA

Innate Pharma S.A.

$2.08

Healthcare / Biotechnology

Market Cap: $232.34M
P/E: unprofitable

ABOS

Acumen Pharmaceuticals, Inc.

$3.18

Healthcare / Biotechnology

Market Cap: $229.97M
P/E: unprofitable

SLGL

Sol-Gel Technologies Ltd.

$69.52

Healthcare / Biotechnology

Market Cap: $227.61M
P/E: unprofitable

TNXP

Tonix Pharmaceuticals Holding Corp.

$13.14

Healthcare / Biotechnology

Market Cap: $225.36M
P/E: unprofitable

KROS

Keros Therapeutics, Inc.

$11.32

Healthcare / Biotechnology

Market Cap: $224.44M
P/E: unprofitable

ANTX

AN2 Therapeutics, Inc.

$5.89

Healthcare / Biotechnology

Market Cap: $222.27M
P/E: unprofitable

CHRS

Coherus Oncology, Inc.

$1.42

Healthcare / Biotechnology

Market Cap: $219.39M
P/E: unprofitable

ARMP

Armata Pharmaceuticals, Inc.

$5.84

Healthcare / Biotechnology

Market Cap: $217.14M
P/E: unprofitable

VYGR

Voyager Therapeutics, Inc.

$3.51

Healthcare / Biotechnology

Market Cap: $216.28M
P/E: unprofitable

PLX

Protalix BioTherapeutics, Inc.

$2.67

Healthcare / Biotechnology

Market Cap: $215.13M
P/E: 11.6

PEPG

PepGen Inc.

$3.11

Healthcare / Biotechnology

Market Cap: $215.12M
P/E: unprofitable

CRBP

Corbus Pharmaceuticals Holdings, Inc.

$11.08

Healthcare / Biotechnology

Market Cap: $214.30M
P/E: unprofitable

NERV

Minerva Neurosciences, Inc.

$4.43

Healthcare / Biotechnology

Market Cap: $211.52M
P/E: unprofitable

Showing 301–350 of 656 · ranked by market capitalization

Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.